Rare diseases
Investigational molecules
Locations
Study of Atezolizumab, Trastuzumab, and Vinorelbine for Patients with Advanced HER2-Positive Breast Cancer
SpainStudy on Reduced Dose Intensity of Pembrolizumab and Drug Combination for Patients with Advanced or Metastatic Cancer Responding to Standard Immunotherapy
FranceStudy on Itacitinib for Treating Non-Severe Hemophagocytic Lymphohistiocytosis in Adults
FranceStudy of Visugromab and Nivolumab for Patients with Muscle-Invasive Bladder Cancer Who Cannot or Refuse Cisplatin Chemotherapy
ItalyAccess to Mepolizumab for Patients with Hypereosinophilic Syndrome
PolandStudy on the Effects of ATL1102 for Nonambulatory Patients with Duchenne Muscular Dystrophy
BulgariaStudy on Troriluzole for Patients with Obsessive Compulsive Disorder Not Responding to Current Treatment
ItalyStudy of Zolbetuximab and CAPOX for Patients with Advanced Gastric or Gastroesophageal Junction Cancer
PortugalStudy comparing iberdomide, daratumumab and dexamethasone versus daratumumab, bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma
AustriaStudy on the Effects of Mitapivat for Patients with Transfusion-Dependent Alpha or Beta Thalassemia
BulgariaStudy on Personalized Dosing of Natalizumab for Patients with Relapsing-Remitting Multiple Sclerosis
The NetherlandsStudy on the Effectiveness and Safety of Cariprazine for Adolescents (13-17 years) with Schizophrenia
BulgariaTell us about your condition – we search every trial in Europe and connect you with the right site.
